Mechanistic Modeling of cfDNA Fragmentome Dynamics Predicts Progression to Immunotherapy
BackgroundPlasma cell-free DNA (cfDNA) shows promise as predictive cancer biomarker, but mechanisms governing cfDNA production/fragmentation/elimination dynamics, and their relationships with tumor burden and disease progression, remain poorly understood.Methods We developed a mechanistic model jointly describing short (75-<580 bp) and long (≥580 ...
Nguyen Phuong, Linh +9 more
openaire +1 more source
Early Cancer Detection: What's Going on and What's Next. [PDF]
Di Carlo E.
europepmc +1 more source
DNAvi: integration, statistics, and visualization of cell-free DNA fragment traces. [PDF]
Hess A, Seelow D, Kretzmer H.
europepmc +1 more source
A Novel Cell-Free DNA Fragmentomic Assay and Its Application for Monitoring Disease Progression in Real Time for Stage IV Cancer Patients. [PDF]
Sinha SK +5 more
europepmc +1 more source
Liquid biopsies for the diagnosis of early-stage gastric cancer: A 5-year systematic review. [PDF]
Papaioannou E +6 more
europepmc +1 more source
Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights
Yasine, Malki, Y M Dennis, Lo
openaire +2 more sources
Diagnostic Accuracy of Blood-Based cfDNA/ctDNA Tests for Colorectal Cancer-A Systematic Review and Meta-Analysis. [PDF]
Rose JH +6 more
europepmc +1 more source
Liquid biopsy in the clinical management of tumor of urinary system: current status and future developments. [PDF]
Xu R +6 more
europepmc +1 more source
Correction: Artificial intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine. [PDF]
Sahoo K +6 more
europepmc +1 more source
Liquid Biopsy in Advanced Prostate Cancer. [PDF]
Mediavilla-Medel P +3 more
europepmc +1 more source

